Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction.

Achari AE, Jain SK.

Int J Mol Sci. 2017 Jun 21;18(6). pii: E1321. doi: 10.3390/ijms18061321. Review.

2.

CD4+ T lymphocytes produce adiponectin in response to transplants.

Danturti S, Keslar KS, Steinhoff LR, Fan R, Dvorina N, Valujskikh A, Fairchild RL, Baldwin WM 3rd.

JCI Insight. 2017 Jun 15;2(12). pii: 89641. doi: 10.1172/jci.insight.89641. [Epub ahead of print]

3.

Effect of adiponectin on macrophage reverse cholesterol transport in adiponectin-/- mice and its mechanism.

Wang Y, Wang X, Guo Y, Bian Y, Bai R, Liang B, Xiao C.

Exp Ther Med. 2017 Jun;13(6):2757-2762. doi: 10.3892/etm.2017.4321. Epub 2017 Apr 10.

4.

Adiponectin Is Involved in Connective Tissue Growth Factor-Induced Proliferation, Migration and Overproduction of the Extracellular Matrix in Keloid Fibroblasts.

Luo L, Li J, Liu H, Jian X, Zou Q, Zhao Q, Le Q, Chen H, Gao X, He C.

Int J Mol Sci. 2017 May 12;18(5). pii: E1044. doi: 10.3390/ijms18051044.

5.

The unique prodomain of T-cadherin plays a key role in adiponectin binding with the essential extracellular cadherin repeats 1 and 2.

Fukuda S, Kita S, Obata Y, Fujishima Y, Nagao H, Masuda S, Tanaka Y, Nishizawa H, Funahashi T, Takagi J, Maeda N, Shimomura I.

J Biol Chem. 2017 May 12;292(19):7840-7849. doi: 10.1074/jbc.M117.780734. Epub 2017 Mar 21.

PMID:
28325833
6.

Vascular transcriptome profiling identifies Sphingosine kinase 1 as a modulator of angiotensin II-induced vascular dysfunction.

Siedlinski M, Nosalski R, Szczepaniak P, Ludwig-Gałęzowska AH, Mikołajczyk T, Filip M, Osmenda G, Wilk G, Nowak M, Wołkow P, Guzik TJ.

Sci Rep. 2017 Mar 9;7:44131. doi: 10.1038/srep44131.

7.

Adiponectin confers protection from acute colitis and restricts a B cell immune response.

Obeid S, Wankell M, Charrez B, Sternberg J, Kreuter R, Esmaili S, Ramezani-Moghadam M, Devine C, Read S, Bhathal P, Lopata A, Ahlensteil G, Qiao L, George J, Hebbard L.

J Biol Chem. 2017 Apr 21;292(16):6569-6582. doi: 10.1074/jbc.M115.712646. Epub 2017 Mar 3.

PMID:
28258220
8.

EPRS is a critical mTORC1-S6K1 effector that influences adiposity in mice.

Arif A, Terenzi F, Potdar AA, Jia J, Sacks J, China A, Halawani D, Vasu K, Li X, Brown JM, Chen J, Kozma SC, Thomas G, Fox PL.

Nature. 2017 Feb 16;542(7641):357-361. doi: 10.1038/nature21380. Epub 2017 Feb 8.

PMID:
28178239
9.

Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease.

Fuster JJ, Ouchi N, Gokce N, Walsh K.

Circ Res. 2016 May 27;118(11):1786-807. doi: 10.1161/CIRCRESAHA.115.306885. Review.

10.

Review: adiponectin in retinopathy.

Fu Z, Gong Y, Löfqvist C, Hellström A, Smith LE.

Biochim Biophys Acta. 2016 Aug;1862(8):1392-400. doi: 10.1016/j.bbadis.2016.05.002. Epub 2016 May 4. Review.

PMID:
27155572
11.

Adiponectin, the past two decades.

Wang ZV, Scherer PE.

J Mol Cell Biol. 2016 Apr;8(2):93-100. doi: 10.1093/jmcb/mjw011. Epub 2016 Mar 18.

12.

Adiponectin: a versatile player of innate immunity.

Luo Y, Liu M.

J Mol Cell Biol. 2016 Apr;8(2):120-8. doi: 10.1093/jmcb/mjw012. Epub 2016 Mar 18. Review.

13.

Adiponectin signaling and function in insulin target tissues.

Ruan H, Dong LQ.

J Mol Cell Biol. 2016 Apr;8(2):101-9. doi: 10.1093/jmcb/mjw014. Epub 2016 Mar 18. Review.

14.

Heterogeneity of white adipose tissue: molecular basis and clinical implications.

Kwok KH, Lam KS, Xu A.

Exp Mol Med. 2016 Mar 11;48:e215. doi: 10.1038/emm.2016.5. Review.

15.

Adiponectin as an anti-fibrotic and anti-inflammatory adipokine in the liver.

Park PH, Sanz-Garcia C, Nagy LE.

Curr Pathobiol Rep. 2015 Dec 1;3(4):243-252. Epub 2015 Sep 30.

16.

Genetic variants of CDH13 determine the susceptibility to chronic obstructive pulmonary disease in a Chinese population.

Yuan YM, Zhang JL, Xu SC, Ye RS, Xu D, Zhang Y, Zhang YJ, Chen YL, Liu YL, Su ZG.

Acta Pharmacol Sin. 2016 Mar;37(3):390-7. doi: 10.1038/aps.2015.158. Epub 2016 Jan 25.

17.

Adiponectin downregulation is associated with volume overload-induced myocyte dysfunction in rats.

Wang LL, Miller D, Wanders D, Nanayakkara G, Amin R, Judd R, Morrison EE, Zhong JM.

Acta Pharmacol Sin. 2016 Feb;37(2):187-95. doi: 10.1038/aps.2015.84. Epub 2015 Nov 30.

18.

Differential Associations between CDH13 Genotypes, Adiponectin Levels, and Circulating Levels of Cellular Adhesive Molecules.

Teng MS, Wu S, Hsu LA, Chou HH, Ko YL.

Mediators Inflamm. 2015;2015:635751. doi: 10.1155/2015/635751. Epub 2015 Oct 27.

19.

Cadherin-13, a risk gene for ADHD and comorbid disorders, impacts GABAergic function in hippocampus and cognition.

Rivero O, Selten MM, Sich S, Popp S, Bacmeister L, Amendola E, Negwer M, Schubert D, Proft F, Kiser D, Schmitt AG, Gross C, Kolk SM, Strekalova T, van den Hove D, Resink TJ, Nadif Kasri N, Lesch KP.

Transl Psychiatry. 2015 Oct 13;5:e655. doi: 10.1038/tp.2015.152.

20.

Detection of T-Cadherin Expression in Mouse Embryos.

Rubina KA, Smutova VA, Semenova ML, Poliakov AA, Gerety S, Wilkinson D, Surkova EI, Semina EV, Sysoeva VY, Tkachuk VA.

Acta Naturae. 2015 Apr-Jun;7(2):87-94.

Supplemental Content

Support Center